August 26, 2022, Wilmington, Delaware, BUSINESS WIRE.Incyte announced that the U.S. Food and Drug Administration (FDA) has approved pemigatinib® (pemi···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 81
Pemigatinib is developed by Incyte Corporation, USA. In April 2020, the U.S. Food and Drug Administration (FDA) approved pemigatinib for the treatment···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 86
Pemigatinib has proven therapeutic activity in patients with previously treated locally advanced/metastatic cholangiocarcinoma with FGFR2 fusions/rear···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 92
Properly understanding the timing of pemigatinib administration, adjusting the appropriate dosage, and its interactions with food are crucial for impr···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 82
While pemigatinib exerts its therapeutic effect, it may also cause different types and degrees of adverse reactions due to individual differences in p···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 91
The price of Pemigatinib is subject to fluctuations due to factors such as drug specifications, region, medical insurance policies, and purchasing cha···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 80
Pemigatinib is a targeted therapy drug for specific cholangiocarcinoma patients. Its price is affected by factors such as dosage, region, and medical ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 80
Incyte recently announced that the European Commission (EC) has approved Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 87
In April 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Pemazyre (pemigatinib) oral tablets, developed by Incyte, f···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 86
Store palbociclib in its original blister pack at a temperature of 68°F to 77°F (20°C to 25°C).Keep the medication out of the reach of children.【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 88
Inform your healthcare provider about all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 85
In the event of an accidental overdose of palbociclib, contact your healthcare provider immediately or proceed directly to the nearest hospital emerge···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 87
If you skip a dose of palbociclib or experience vomiting shortly after taking a dose, do not administer an additional dose on the same day. Resume you···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 89
On August 26, 2022, Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Pemazyre (pemigatinib) for the treatment of adult p···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 87
The price of palbociclib is significantly affected by drug specifications, regional policies, and purchasing channels. In China, the price per box typ···【Read More】
Update: 2026-04-08Source: Haiou HealthViews: 87
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



